Clinical Trial Update: the Efficacy and Safety of Sugammadex in Children 0-2 Years Old [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of sugammadex in children aged 0-2 years for anesthesia-related use, with a status listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Beta-thalassemia
• Cancer
• Hepatic Metastases
• Hepatoblastoma
• Tumor

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Anesthesia, Pediatric Cancer | Phase 2, Phase 3 | Status: UNKNOWN